Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong M. Shin, MD
Emory University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Westmead Breast Centre at Nsw Breast Cancer Institute
Westmead, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Instituto de Enfermedades Neoplasicas
Lima, Peru
- Mbccop - San Juan
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- Veterans Affairs Medical Center - San Juan
San Juan, Puerto Rico
- Pretoria Academic Hospital
Pretoria, South Africa
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Ccop - Mayo Clinic Scottsdale Oncology Program
Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford Cancer Center at Stanford University Medical Center
Stanford, California, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Mbccop - Howard University Cancer Center
Washington D.C., District of Columbia, United States
- Veterans Affairs Medical Center - Gainesville
Gainesville, Florida, United States
- Veterans Affairs Medical Center - Miami
Miami, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Veterans Affairs Medical Center - Tampa (haley)
Tampa, Florida, United States
- Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Lakeside Chicago
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Veterans Affairs Medical Center - Indianapolis (roudebush)
Indianapolis, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Lutheran Hospital
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Burgess Health Center
Onawa, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Veterans Affairs Medical Center - Wichita
Wichita, Kansas, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Mbccop - Lsu Health Sciences Center
New Orleans, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Nov 2003
- Primary completion
- 31 Dec 2004
- Completion
- 1 May 2009
- Last update posted
- 15 Jun 2023
- Registered enrollment
- —
- Registry id
- NCT00054561
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.